These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Stenting small coronary arteries: works in progress. Holmes DR JAMA; 2004 Dec; 292(22):2777-8. PubMed ID: 15585739 [No Abstract] [Full Text] [Related]
33. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME; JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618 [TBL] [Abstract][Full Text] [Related]
34. [Drug-eluting stents: do they keep their promises?]. Nordmann A Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178 [No Abstract] [Full Text] [Related]
35. Drug-Coated Balloon Treatment as Default Strategy for DES-ISR. Scheller B; Ong PJ; Kleber F J Am Coll Cardiol; 2016 Jan; 67(3):346-7. PubMed ID: 26796403 [No Abstract] [Full Text] [Related]
36. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603 [TBL] [Abstract][Full Text] [Related]
37. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Mantilla R; Morís C; Cequier A; Sabaté M; Escaned J; Moreno R; Bañuelos C; Suárez A; Macaya C; J Am Coll Cardiol; 2006 Jun; 47(11):2152-60. PubMed ID: 16750678 [TBL] [Abstract][Full Text] [Related]
38. Sirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial: a call for caution? Rodriguez AE; Waksman R JACC Cardiovasc Interv; 2009 Jan; 2(1):75-6; author reply 76-7. PubMed ID: 19463404 [No Abstract] [Full Text] [Related]
39. "At least but not at last" equivalent! Bonan R Catheter Cardiovasc Interv; 2004 Jul; 62(3):289. PubMed ID: 15224290 [No Abstract] [Full Text] [Related]
40. Reply: Drug-Coated Balloon Treatment as Default Strategy for DES-ISR. Alfonso F; Pérez Vizcayno MJ; Cárdenas A; García Del Blanco B; García-Touchard A; López-Minguez JR J Am Coll Cardiol; 2016 Jan; 67(3):348-9. PubMed ID: 26796404 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]